InMed Pharmaceuticals Inc.INMNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank57
3Y CAGR-26.8%
5Y CAGR-13.3%
Year-over-Year Change
Research and development spending
3Y CAGR
-26.8%/yr
vs +48.0%/yr prior
5Y CAGR
-13.3%/yr
Recent deceleration
Acceleration
-74.8pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $2.85M | -11.3% |
| 2024 | $3.22M | -13.8% |
| 2023 | $3.73M | -48.8% |
| 2022 | $7.28M | +10.0% |
| 2021 | $6.62M | +13.9% |
| 2020 | $5.81M | +35.3% |
| 2019 | $4.30M | +183.1% |
| 2018 | $1.52M | +164.4% |
| 2017 | $573723.00 | +95.9% |
| 2016 | $292840.00 | - |